Alterity Therapeutics
ATHE
14 hedge funds and large institutions have $975K invested in Alterity Therapeutics in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
97% more capital invested
Capital invested by funds: $494K → $975K (+$481K)
17% more funds holding
Funds holding: 12 → 14 (+2)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$91.2K |
| 2 |
Renaissance Technologies
New York
|
+$54.4K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$38.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$23.3K |
| 5 |
Morgan Stanley
New York
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.35K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $373K | +$14.8K | +743 | +4% |
|
|
CWM
2
Cornerstone Wealth Management
St. Peters,
Missouri
| $333K | +$1.25K | +63 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $130K | +$91.2K | +4,592 | +201% |
|
|
4
Renaissance Technologies
New York
| $52K | +$54.4K | +2,742 | New |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $50K | +$38.3K | +1,930 | +260% |
|
|
TSS
6
Two Sigma Securities
New York
| $22K | +$23.3K | +1,172 | New |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $5K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $3K | -$9.35K | -471 | -77% |
|
|
OIA
9
Optimum Investment Advisors
Chicago,
Illinois
| $3K | – | – | – |
|
|
AIM
10
Advantage Investment Management
Cedar Rapids,
Iowa
| $2K | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
LC
12
Landaas & Company
Milwaukee,
Wisconsin
| $1K | +$1.33K | +67 | New |
|
|
APA
13
American Portfolios Advisors
Holbrook,
New York
| $157 | – | – | – |
|
|
14
Wells Fargo
San Francisco,
California
| – | -$2K | -83 | Closed |
|
ATHE Hedge Fund Activity: Q2 2018 in Review
14 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q2 2018, worth a combined $975K — up 97% from $494K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATHE positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $91.2K. The largest seller was UBS Group, cutting an estimated $9.35K.
- 14 institutional investors held Alterity Therapeutics (ATHE) as of Q2 2018, up from 12 in Q1 2018.
- Funds reported $975K of Alterity Therapeutics stock for Q2 2018, up 97% quarter-over-quarter.
- 4 funds opened new Alterity Therapeutics positions in Q2 2018 and 2 closed out, a net change of +2 holders.
- The largest Alterity Therapeutics buyer in Q2 2018 was Susquehanna International Group, an estimated $91.2K added.
- The largest Alterity Therapeutics seller in Q2 2018 was UBS Group, an estimated $9.35K sold.
Based on aggregated 13F filings for Q2 2018.